| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0045(19990215)38:3<208::AID-PROS5>3.0.CO;2-4 |
| P8608 | Fatcat ID | release_yi6r2loryff2jda2fwu7qagpde |
| P698 | PubMed publication ID | 10068345 |
| P50 | author | Mark Goepel | Q107851390 |
| Herbert Rübben | Q107851709 | ||
| P2093 | author name string | Michel MC | |
| Krege S | |||
| Hecker U | |||
| P2860 | cites work | (-)-Discretamine, a selective alpha 1D-adrenoceptor antagonist, isolated from Fissistigma glaucescens | Q24679449 |
| Haemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats | Q35870914 | ||
| Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia | Q71022039 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 208-215 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | The Prostate | Q7758608 |
| P1476 | title | Saw palmetto extracts potently and noncompetitively inhibit human alpha1-adrenoceptors in vitro | |
| P478 | volume | 38 |
| Q34334931 | Alpha-blockers and lower urinary tract function: more than smooth muscle relaxation? |
| Q34707777 | Alpha-blockers: an effective treatment for prostatitis? |
| Q54962708 | Best Prophylactic Strategy in Groups at Risk of Intraoperative Floppy Iris Syndrome Development: Comparison Between Atropine Instillation and Adrenaline Intracameral Injection. |
| Q38235157 | Cardiovascular and ocular safety of α1-adrenoceptor antagonists in the treatment of male lower urinary tract symptoms |
| Q64102581 | Combined and Extracts (WS 1541) Exert Anti-proliferative and Anti-inflammatory Effects in a Mouse Model of Benign Prostate Hyperplasia |
| Q31913030 | Do saw palmetto extracts block human alpha1-adrenoceptor subtypes in vivo? |
| Q37661055 | Effects of D-004, a lipid extract from Cuban royal palm fruit, on inhibiting prostatic hypertrophy induced with testosterone or dihydrotestosterone in a rat model: A randomized, controlled study |
| Q73179867 | Effects of Pygeum africanum extract (Tadenan) on vasoactive intestinal peptide receptors, G proteins, and adenylyl cyclase in rat ventral prostate |
| Q40215681 | Effects of Saw Palmetto Extract on Urodynamic Parameters, Bladder Muscarinic and Purinergic Receptors and Urinary Cytokines in Rats with Cyclophosphamide-Induced Cystitis |
| Q43753353 | Effects of natural products and nutraceuticals on steroid hormone-regulated gene expression |
| Q92421021 | Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial |
| Q37639596 | Established medical therapy for benign prostatic hyperplasia |
| Q33764040 | Estrogen in the etiopathogenesis of BPH. |
| Q34797013 | Herbs for benign prostatic hyperplasia |
| Q53272579 | Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms--a placebo-controlled, double-blind, multicenter trial. |
| Q80485600 | Muscarinic and alpha 1-adrenergic receptor binding characteristics of saw palmetto extract in rat lower urinary tract |
| Q37406930 | Pharmacological effects of saw palmetto extract in the lower urinary tract |
| Q35877386 | Saw palmetto and benign prostatic hyperplasia |
| Q36174671 | Saw palmetto and finasteride in the treatment of category-III prostatitis/chronic pelvic pain syndrome |
| Q42828508 | Saw palmetto ethanol extract inhibits adipocyte differentiation |
| Q38845916 | Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia |
| Q33701372 | Use of herbal products and potential interactions in patients with cardiovascular diseases |
| Q91740309 | Use of saw palmetto (Serenoa repens) extract for benign prostatic hyperplasia |
| Q79826592 | [Stinging nettle root extract (Bazoton-uno) in long term treatment of benign prostatic syndrome (BPS). Results of a randomized, double-blind, placebo controlled multicenter study after 12 months] |
| Q84564028 | [Therapy of benign prostate syndrome (BPS): guidelines of the German Urologists (DGU)] |
Search more.